DE60323135D1 - Heterozyklische verbindungen, ihre herstellung und ihre therapeutische verwendung, besonders als antibakterielle und beta-lactamase inhibitoren - Google Patents
Heterozyklische verbindungen, ihre herstellung und ihre therapeutische verwendung, besonders als antibakterielle und beta-lactamase inhibitorenInfo
- Publication number
- DE60323135D1 DE60323135D1 DE60323135T DE60323135T DE60323135D1 DE 60323135 D1 DE60323135 D1 DE 60323135D1 DE 60323135 T DE60323135 T DE 60323135T DE 60323135 T DE60323135 T DE 60323135T DE 60323135 D1 DE60323135 D1 DE 60323135D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- halo
- conr6r7
- tet
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 125000001475 halogen functional group Chemical group 0.000 abstract 7
- 125000003545 alkoxy group Chemical group 0.000 abstract 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 5
- 229910006069 SO3H Inorganic materials 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000003831 tetrazolyl group Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- PWEBUXCTKOWPCW-UHFFFAOYSA-L squarate Chemical compound [O-]C1=C([O-])C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-L 0.000 abstract 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 1
- -1 CONHOH Chemical group 0.000 abstract 1
- 101100516568 Caenorhabditis elegans nhr-7 gene Proteins 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 229910004727 OSO3H Inorganic materials 0.000 abstract 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 150000003976 azacycloalkanes Chemical class 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 150000003840 hydrochlorides Chemical class 0.000 abstract 1
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/18—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0215428A FR2848210B1 (fr) | 2002-12-06 | 2002-12-06 | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases |
| PCT/FR2003/003523 WO2004052891A1 (fr) | 2002-12-06 | 2003-11-28 | Composes heterocyclique, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60323135D1 true DE60323135D1 (de) | 2008-10-02 |
Family
ID=32320045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60323135T Expired - Lifetime DE60323135D1 (de) | 2002-12-06 | 2003-11-28 | Heterozyklische verbindungen, ihre herstellung und ihre therapeutische verwendung, besonders als antibakterielle und beta-lactamase inhibitoren |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1569935B1 (enExample) |
| JP (1) | JP4954477B2 (enExample) |
| KR (1) | KR101146802B1 (enExample) |
| AT (1) | ATE405567T1 (enExample) |
| AU (1) | AU2003294104A1 (enExample) |
| CA (1) | CA2507607C (enExample) |
| DE (1) | DE60323135D1 (enExample) |
| FR (1) | FR2848210B1 (enExample) |
| WO (1) | WO2004052891A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
| KR101594898B1 (ko) | 2005-07-15 | 2016-02-18 | 알바니 몰레큘라 리써치, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도 |
| ATE529111T1 (de) | 2005-12-07 | 2011-11-15 | Basilea Pharmaceutica Ag | Nützliche monobactam-antibiotika |
| FR2914923B1 (fr) * | 2007-04-12 | 2013-06-14 | Novexel | Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens. |
| FR2921060B1 (fr) * | 2007-09-14 | 2012-06-15 | Novexel | Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires |
| FR2936798B1 (fr) | 2008-10-03 | 2012-09-28 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens. |
| FR2937034B1 (fr) * | 2008-10-10 | 2012-11-23 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens |
| FR2936951B1 (fr) * | 2008-10-10 | 2010-12-03 | Novexel | Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments |
| US8796257B2 (en) | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| US9505761B2 (en) | 2011-12-02 | 2016-11-29 | Fedora Pharmaceuticals Inc. | Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors |
| CA2881169C (en) * | 2012-08-25 | 2020-06-16 | Wockhardt Limited | 1,6-diazabicyclo [3,2,1]octan - 7 - one derivatives and their use in the treatment of bacterial infections |
| UA111925C2 (uk) | 2012-12-11 | 2016-06-24 | Федора Фармасьютікалз Інк. | БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ |
| WO2014141132A1 (en) * | 2013-03-14 | 2014-09-18 | Naeja Pharmaceutical Inc. | NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS |
| BR112017010132B1 (pt) * | 2014-11-17 | 2023-02-14 | Entasis Therapeutics Limited | Combinações e seus usos no tratamento de infecções bacterianas resistentes |
| CA3036557A1 (en) | 2016-09-16 | 2018-03-22 | Entasis Therapeutics Limited | Beta-lactamase inhibitor compounds |
| JOP20190061A1 (ar) | 2016-09-28 | 2019-03-26 | Novartis Ag | مثبطات بيتا-لاكتاماز |
| PL3630111T3 (pl) | 2017-05-08 | 2022-05-23 | Entasis Therapeutics, Inc. | Związki i sposoby leczenia zakażeń bakteryjnych |
| EP3604309A1 (en) | 2018-07-30 | 2020-02-05 | Mutabilis | Heterocyclic compounds and their use in preventing or treating bacterial infections |
| EP3604315A1 (en) * | 2018-07-30 | 2020-02-05 | Mutabilis | Heterocyclic compounds and their use in preventing or treating bacterial infections |
| WO2022047603A1 (en) | 2020-09-01 | 2022-03-10 | Ningxia Academy Of Agriculture And Forestry Sciences | Beta-lactamase inhibitors and their preparation |
| EP4146651B1 (en) | 2021-05-07 | 2026-03-04 | Ningxia Academy of Agriculture and Forestry Sciences | Sulfonylamidine substituted compounds and their use as beta-lactamase inhibitors |
| WO2024227071A1 (en) * | 2023-04-26 | 2024-10-31 | Entasis Therapeutics Limited | Synthesis of durlobactam |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2676230B1 (fr) * | 1991-05-07 | 1993-08-27 | Centre Nat Rech Scient | Nouveaux derives de pyrrolo [1,4]-benzodiazepines, leur procede de preparation et medicaments les contenant. |
| NZ274915A (en) * | 1993-12-29 | 1997-11-24 | Pfizer | N-(hetero)aryl methyl diazabicycloalkane derivatives |
| DE19627431A1 (de) * | 1996-07-08 | 1998-01-15 | Bayer Ag | Heterocyclisch kondensierte Pyridine |
| EP1091944A1 (en) * | 1998-06-30 | 2001-04-18 | Du Pont Pharmaceuticals Company | 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| CO5180550A1 (es) * | 1999-04-19 | 2002-07-30 | Smithkline Beecham Corp | Inhibidores de fab i |
| FR2812635B1 (fr) * | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
| FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
| FR2835186B1 (fr) * | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
-
2002
- 2002-12-06 FR FR0215428A patent/FR2848210B1/fr not_active Expired - Fee Related
-
2003
- 2003-11-28 WO PCT/FR2003/003523 patent/WO2004052891A1/fr not_active Ceased
- 2003-11-28 AU AU2003294104A patent/AU2003294104A1/en not_active Abandoned
- 2003-11-28 JP JP2004558137A patent/JP4954477B2/ja not_active Expired - Fee Related
- 2003-11-28 EP EP03789523A patent/EP1569935B1/fr not_active Expired - Lifetime
- 2003-11-28 CA CA2507607A patent/CA2507607C/fr not_active Expired - Fee Related
- 2003-11-28 DE DE60323135T patent/DE60323135D1/de not_active Expired - Lifetime
- 2003-11-28 KR KR1020057010234A patent/KR101146802B1/ko not_active Expired - Fee Related
- 2003-11-28 AT AT03789523T patent/ATE405567T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006512335A (ja) | 2006-04-13 |
| ATE405567T1 (de) | 2008-09-15 |
| FR2848210B1 (fr) | 2007-10-19 |
| FR2848210A1 (fr) | 2004-06-11 |
| WO2004052891A1 (fr) | 2004-06-24 |
| AU2003294104A1 (en) | 2004-06-30 |
| EP1569935A1 (fr) | 2005-09-07 |
| KR101146802B1 (ko) | 2012-05-21 |
| JP4954477B2 (ja) | 2012-06-13 |
| WO2004052891A8 (fr) | 2005-07-28 |
| CA2507607C (fr) | 2014-06-17 |
| KR20050088302A (ko) | 2005-09-05 |
| EP1569935B1 (fr) | 2008-08-20 |
| CA2507607A1 (fr) | 2004-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE405567T1 (de) | Heterozyklische verbindungen, ihre herstellung und ihre therapeutische verwendung, besonders als antibakterielle und beta-lactamase inhibitoren | |
| MA27433A1 (fr) | Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens | |
| HUP0400017A2 (hu) | Antibakteriális hatóanyakokként alkalmazható nitrogéntartalmú biciklusos heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| AR048346A1 (es) | Piridonas sustituidas como inhibidores de poli(adp-ribosa)-polimerasa (parp), composiciones farmaceuticas que las contienen y el uso de las mismas para el tratamiento de trastornos cardiovasculares y del sistema nervioso central. | |
| AR060316A1 (es) | Azaindoles de utilidad como inhibidores de janus quinasas | |
| ECSP055644A (es) | Derivados de la quinolil-propil-piperidina y su utilización | |
| AR036091A1 (es) | Compuestos heterociclicos,su procedimiento de preparacion, composiciones farmaceuticas y medicamentos, particularmente como agentes anti-bacterianos. | |
| NO982901D0 (no) | Nye barbitursyrederivater, fremgangsmÕter for fremstilling av slike, samt farmas°ytiske midler inneholdende disse forbindelser | |
| AR046793A1 (es) | Derivados de pirazol, antagonistas del receptor de la orexina | |
| JP2010520276A5 (enExample) | ||
| AR083832A1 (es) | DERIVADOS DE TETRAHIDROPIRIDO[3,2-F][1,4]OXAZEPIN-8-AMINA PARA EL TRATAMIENTO DE ENFERMEDADES Ab-RELACIONADAS | |
| HUP0001396A2 (hu) | 3-Amino-3 aril-propán-1-ol-származékok, előállításuk és felhasználásuk | |
| ATE234305T1 (de) | Dihydrofuro-(3,4-b)-chinolein-1-on derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| EA201170097A1 (ru) | Замещенные трициклические производные против нейродегенеративных заболеваний | |
| DE60006583D1 (de) | Neue verbindungen | |
| PT1050531E (pt) | Compostos piridinicos ou piperidinicos substituidos para o tratamento de doencas neurodegenerativas | |
| HUP0500203A2 (hu) | Acil-3-karboxi-fenil-karbamid-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| BRPI0509564A (pt) | derivados pirrolo(2,3-b)piridina, respectivo preparo e respectiva utilização farmacêutica como inibidores de quinases | |
| MY130750A (en) | Pyrimidine derivatives useful as selective cox-2 inhibitors | |
| TW200716553A (en) | 2-methyl-4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives | |
| WO2002096886A8 (en) | Pyrimidine derivatives | |
| NZ238644A (en) | 2-(1-oxo-alkoxy)alkanoic acid derivatives and pharmaceutical compositions thereof | |
| KR970064605A (ko) | 폐암을 치료하기 위한, 나프탈렌 유도체를 함유하는 약학 조성물 | |
| NO955103D0 (no) | Anvendelse av 1,2-broholdige 1,4-dihydropyridiner som legemiddel | |
| NO305439B1 (no) | Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |